SEC Form 4 · accession 0001127602-17-009670
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrea DiFabio
Officer — EVP, Chief Legal Officer
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 28, 2017 | A | 35,019 | $0.00 | A | 35,985 | D | |
| Common StockF3 | Feb 28, 2017 | F | 1,155 | $43.42 | D | 34,830 | D | |
| Common StockF3 | Feb 28, 2017 | F | 368 | $49.56 | D | 34,462 | D | |
| Common StockF3 | Feb 28, 2017 | F | 1,191 | $47.76 | D | 33,271 | D | |
| Common StockF3 | Feb 28, 2017 | F | 532 | $43.42 | D | 32,739 | D | |
| Common StockF3 | Feb 28, 2017 | F | 285 | $49.56 | D | 32,454 | D | |
| Common StockF3 | Feb 28, 2017 | F | 918 | $47.76 | D | 31,536 | D | |
| Common StockF3 | Feb 28, 2017 | F | 718 | $43.42 | D | 30,818 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes restricted stock units granted by Bioverativ Inc. ("Bioverativ") to the reporting person as a result of the conversion of existing Biogen Inc. ("Biogen") cash-settled performance units, market stock units and restricted stock units held by the reporting person prior to the spin-Off of Bioverativ from Biogen on February 1, 2017 ("Spin-Off"), as set forth in an employee matters agreement entered into between Bioverativ and Biogen in connection with the Spin-Off. Restricted stock units that are unvested continue to vest on the dates of the original Biogen awards.
- F2Includes 966 shares acquired in a pro rata distribution by Biogen in connection with the Spin-Off.
- F3Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units.